Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 9Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Mouth Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Uterine Cervical Neoplasms 1Sentinel Lymph Node Biopsy (SLNB) 1Sarcoidosis, Pulmonary 1Sarcoidosis 1Rhabdomyosarcoma 1Recurrence 1Recurent Vulvar Carcinoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Melanoma 1Lymphoma 1Lymphatic Metastasis 1Lung Neoplasms 1HIV Infections 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Eyelid Sebaceous Gland Carcinoma 1Cervical Adenocarcinoma 1Carcinoma, Squamous Cell 1Carcinoma, Ductal 1Anus Neoplasms 1

Interventions

ipatasertib 1Telemedicine 1Specimen Handling 1Sentinel Lymph Node Biopsy 1Ovariectomy 1Megestrol Acetate 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Hysterectomy 1Health Promotion 1Exercise Test 1Educational Status 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma × Sentinel Lymph Node Biopsy × 1 year × Clear all
NCT04604613 2026-03-09

Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

M.D. Anderson Cancer Center

Active not recruiting
518 enrolled
Gynecologic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡